XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value of Assets and Liabilities (Tables)
 12 Months Ended
Dec. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of derivative instruments in statement of financial position, fair value
As of December 30, 2023 and December 31, 2022, the fair values of our derivative financial instrument and their classifications on the Consolidated Balance Sheets were as follows:

Fiscal Year Ended

(in thousands)		Consolidated Balance Sheet ClassificationDecember 30, 2023December 31, 2022
Derivatives designated as hedging instruments
Interest rate swap agreement:
Designated as cash flow hedgePrepaid expenses and other current assets$3,712 $3,939 
Other long-term assets$2,140 $4,740 
Derivatives not designated as hedging instruments
Foreign exchange forward contractPrepaid expenses and other current assets$— $6,186 
Schedule of derivative instruments, gain (loss)
The pre-tax gains recognized on derivative financial instruments in the Consolidated Statements of Operations for the fiscal year ended December 30, 2023 and December 31, 2022 were as follows:
Fiscal Year Ended
(in thousands)Classification of Gain Recognized in the Consolidated Statements of OperationsDecember 30, 2023December 31, 2022
Derivatives designated as cash flow hedges
Interest rate swap agreementInterest expense, net$(4,551)(100)
Derivatives not designated as hedging instruments
Foreign exchange forward contractForeign exchange gain$(52)(6,128)

The pre-tax loss (gain) recognized on derivative financial instruments in the Consolidated Statements of Comprehensive Income for the fiscal year ended December 30, 2023 and December 31, 2022 was as follows:
Fiscal Year Ended
(in thousands)December 30, 2023December 31, 2022
Derivatives designated as cash flow hedges
Interest rate swap agreement$2,827 $(8,679)
Schedule of fair value, assets measured on recurring basis
The following table presents assets measured at fair value by classification within the fair value hierarchy as of December 30, 2023:
 
 Fair Value Measurements Using 
(in thousands)
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
Cash equivalents$415,788 $— $— $415,788 
Investments in equity securities10,832 — — 10,832 
Mutual funds20,148 — — 20,148 
Total:$446,768 $— $— $446,768 
 
The following table presents assets measured at fair value by classification within the fair value hierarchy as of December 31, 2022:
 
 Fair Value Measurements Using 
(in thousands)
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
Cash equivalents$304,101 $— $— $304,101 
Investments in equity securities10,653 — — 10,653 
Mutual funds14,094 — — 14,094 
Total:$328,848 $— $— $328,848 
Schedule of fair value, by balance sheet grouping
The carrying value and estimated fair values of the Company’s Euro Senior Notes, Series A and Series B and USD Senior Notes, Series A and Series B, as of December 30, 2023 and December 31, 2022 were as follows:
 
 December 30, 2023December 31, 2022
(in thousands)
Carrying
Value		Estimated
Fair Value		Carrying
Value		Estimated
Fair Value
Euro Senior Notes, Series A due 2023$— $— $124,716 $122,270 
Euro Senior Notes, Series B due 2028105,246 96,532 101,265 87,119 
USD Senior Notes, Series B due 2027100,000 96,127 100,000 93,764 
USD Senior Notes, Series A due 202550,000 49,070 50,000 48,145 
USD Senior Notes, Series B due 2030125,000 115,687 125,000 112,028 
USD Senior Notes, due 2032100,000 93,228 100,000 90,131